Development of Vaccine Formulations Effective Against NIAID Priority Pathogens | Federal Compass

Free Market Report: Trends & Observations
Development of Vaccine Formulations Effective Against NIAID Priority Pathogens


Prepare yourself for competition by understanding federal market trends. Is this the right pursuit for my organization? How is the government buying my product and services? Is there an upcoming recompete for future work?


Contracting Agency/Office
Health and Human Services»National Institutes of Health»National Institute of Allergy and Infectious Diseases»NIAID - Division of Extramural Activities»NIAID-DOEA Office of Acquisitions
NAICS
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Competition Set-Aside Type
NONE

Award Type
Definitive Contract
Award Date
07/23/2014
Expiration Date
No. of Awards
4
No. of Offers
7

Obligations by Fiscal Year

prime obligations by fiscal year

Start Your Free Account Today

Gain Full Access to This Report and...
Contract Opportunities
Pipeline Management
Award Research
Funding Analysis
Partner Identification
Industry and Market Intel
Agency Spending Trends
Competitive Insights

Federal Compass is software designed for today’s federal market.

Explore how the right intel and process can help lead your team to greater success.

Create Free Account

Enjoy instant access to the Federal Compass platform

Contracting Resources